Handunnetti SM, Anderson MA, Burbury KI, Thompson PA, et al. Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions. Blood 2024 Apr 25:blood.2023023388. doi: 10.1182/blood.2023023388.
PMID: 38662991